Free school meals: a recipe for healthier, happier kids?
NCT ID NCT07389421
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looks at how a national program providing free school meals affects the health, well-being, and learning of Danish children aged 10 to 15. Over 3,200 kids from schools offering free meals will be compared to those without. Researchers will track changes in quality of life, mental health, and cognitive skills over 1.5 years, using surveys and health measurements.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- free school meals (behavioral intervention)
- What this could lead to
- If successful, this could show that providing free, nutritious school meals improves children's health, well-being, and learning, and may help reduce social inequalities.
- What could go wrong
- This is an observational natural experiment, not a controlled trial, so results may be influenced by other factors. The study is not yet recruiting and outcomes are based on questionnaires and cognitive tests, which may not capture long-term effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test